✨ Free AI Report
Prim, S.A.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Prim, S.A.
Company Research

Prim, S.A.: Business Overview, Financials & Competitive Analysis

Prim, S.A. scores 6/10 on the AskCyborg Cyborg Score (Solid). Stable, internationally diversified orthopedic and medical device manufacturer with steady growth, solid financials, and strategic market positioning in healthcare innovation. Revenue grew 7.73% in 2024 to €233.36 million, demonstrating market traction. The company maintains healthy balance sheet metrics with current ratio of 2.23 and ROE of 9.14%. However, earnings declined.

What is Prim, S.A.'s industry? Prim, S.A. (prim.es) operates in Medical Instruments & Supplies / Orthopedic Devices Healthcare. AskCyborg classifies Prim, S.A. under Medical Instruments & Supplies / Orthopedic Devices Healthcare in its company registry.

Prim, S.A. provides health technology, mobility, and health care products including orthopaedic supports and braces for upper and lower limbs in Spain. The company exports to over 90 countries, establishing a strong i...

6/ 10Solid

Cyborg Score thesis

Stable, internationally diversified orthopedic and medical device manufacturer with steady growth, solid financials, and...

Read the full analyst-debate transcript →
Industry Medical Instruments & Supplies / Orthopedic Devices Healthcare
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Prim, S.A. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Prim, S.A.

AskCyborg analysts argue the bull and bear cases for Prim, S.A. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Prim, S.A. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Prim, S.A. Overview

Pro stress-test →

Prim, S.A. provides health technology, mobility, and health care products including orthopaedic supports and braces for upper and lower limbs in Spain. The company exports to over 90 countries, establishing a strong international presence in the medical devices sector.

Strategic Profile

Pro stress-test →

Prim is a vertically-integrated specialised company which supplies innovative and proven technology to the healthcare sector, with strong teamwork culture, agile team, and technical expertise, backed by a strong financial position. The company operates PrimAcademy, an offline and digital training platform, differentiating itself through customer education and engagement.

Competitive Landscape

Pro stress-test →

Prim competes in the orthopedic devices and medical supplies market against larger multinational manufacturers like Ottobock, Össur, and regional players. The company differentiates through its specialized product portfolio, vertically-integrated operations, and 150+ year heritage. Margins remain compressed due to competition and healthcare sector pricing pressures.

Industry Context

Prim, S.A. operates in Medical Instruments & Supplies / Orthopedic Devices Healthcare.

Key facts

Founded: 1870 · Headquarters: Móstoles, Spain · Employees: 958 · Revenue: €233.36M (2024) · Market cap: $196M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Prim, S.A..

  • 2024 revenue reached €233.36 million (+7.73% YoY), showing consistent organic growth
  • Listed on Spanish Stock Exchange since 1985, demonstrating decades of market stability
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2025Market cap approximately $196 million USD with 958 employees
  • 2024Revenue of €233.36 million (+7.73% growth), earnings of €10.92 million (-13.83%)
  • +1 moreTrack every material event for Prim, S.A. as it happens. Explore monitoring →
Get alerted when Prim, S.A. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Prosthetic and Orthotic SolutionsGlobal orthopedic and prosthetic devices manufacturer→Orthopaedic TechnologyInternational leader in orthopedic prosthetics and mobility solutions→Medical Device DistributionLocal medical supply and orthopedic distribution networks→

Compare Prim, S.A. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Prim, S.A. operates in Medical Instruments & Supplies / Orthopedic Devices Healthcare. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Instruments & Supplies / Orthopedic Devices Healthcare research →
NEW · MCP server

Ask your AI assistant about Prim, S.A.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Prim, S.A. and its top competitor on Cyborg Score”
“What did Prim, S.A. do this quarter?”
“Is Prim, S.A. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Prim, S.A. do?+
Prim, S.A. provides health technology, mobility, and health care products including orthopaedic supports and braces for upper and lower limbs in Spain. The company exports to over 90 countries, establishing a strong i...
What is Prim, S.A.'s Cyborg Score?+
Prim, S.A. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Prim, S.A.'s main competitors?+
Named competitors include Prosthetic and Orthotic Solutions, Orthopaedic Technology, Medical Device Distribution. The full competitive landscape is in the AskCyborg report.
How can I get the full Prim, S.A. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Prim, S.A. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Prim, S.A. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Instruments & Supplies research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7IVF Hartmann Holding AG7Olympus Corporation6Prim, S.A.5Carl Zeiss Meditec AG